TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CLDX

Celldex Therapeutics Inc

Healthcare · Biotechnology

38.20$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Celldex Therapeutics Inc (CLDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1.5 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CLDX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.6 5.5 6.8 13 9.5 3.6 7.4 4.7 2.4 6.9 7.0 1.5
3.4 4.0 102 96 66 43 43 53 82 118 164
0.2 1.5 -95 -83 -57 -39 -35 -49 -80 -111 -157 1.5
104 100 103 96 66 43 41 57 82 118 164 245
21 34 36 25 19 15 14 20 27 31 39 44
123 35 38 38 100 16 28 23 35 43 39 289
-122 -130 -133 -122 -156 -55 -63 -71 -115 -155 -195 -287
0.0 0.0 0.0 16 151 0.0 19 0.1 2.9
-118 -127 -129 -117 -152 -51 -61 -71 -112 -141 -158 -259
-4.4 -2.3 -8.8 -24 -0.8 -0.5 -1.2 -0.2 10 2.8 -158
-118 -127 -129 -93 -151 -51 -60 -71 -112 -141 -158 -259
-115 -126 -124 -104 -73 -50 -46 -66 -104 -139 -155 -255

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?